Market Analysis

Towards a sustainable European market for off-patent biologics

Posted by:

As pioneers with regards to the regulatory approval and use of biosimilars, the EU is now reaping the economic benefits, with increased patient access and healthcare system efficiencies generated through competition on the one hand and continued innovation on the other – an essential equilibrium for securing a sustainable future for the European biologics market.

However, the increasing focus on maximizing short-term savings and the high diversity of policies governing the daily practice of off-patent biologics may eventually undermine this goal.

It is imperative to ask: How should the policy ...

Continue Reading →
0

Pugatch Consilium is releasing the sixth edition of the Building the Bioeconomy

Posted by:

Pugatch Consilium is today releasing the sixth edition of the Building the Bioeconomy, a series of papers commissioned by the Biotechnology Industry Organization. Since 2013, the series has taken the pulse of biotechnology policies in the main economies worldwide, and has shown that policy choices are key determinants of success in growing biotechnology sectors.
This year’s edition adds to the analysis eleven countries, further increasing the geographic and economic diversity of the countries sampled. Yet, the findings of the report ...

Continue Reading →
0

Taiwan is accelerating towards leadership of the Fourth Industrial Revolution

Posted by:

Professor Meir Pugatch spoke last week at the forum “How to Accelerate Taiwan Biomedical Policy Momentum as an Asia-Pacific Biomedical R&D Hub” hosted by the International Research-based Pharmaceutical Manufacturers Association (IRPMA), and included the Vice President of Taiwan Chien-Jen Chen and Minister Ming-Hsin Kung from the Executive Yuan, as well as leading figures from Taiwan’s Government, academia and industry.

Professor Pugatch presented a comprehensive analysis of Taiwan’s competitiveness in the biotech sector, as well as recent improvements to, and remaining challenges in, Taiwan’s path to leadership in global ...

Continue Reading →
0

The EU Orphan Regulation: A success story in driving R&D of orphan medicines in the EU – but what about access?

Posted by:

Pugatch Consilium is today releasing a new study – Benchmarking Success: Evaluating the Orphan Regulation and its impact on patients and rare disease R&D in the European Union.

Within the context of the European Commission’s Evaluation of the legislation on medicines for children and rare diseases, the study examines whether the EU Orphan Regulation has accomplished its aim of incentivising the development and introduction of new therapies for rare diseases onto the EU market, and explores some of the current and ...

Continue Reading →
0

Positioning Ireland as a global innovation leader in the 4th Industrial Revolution

Posted by:

Professor Pugatch delivered a keynote presentation at the 25th Annual Conference of the Irish Pharmaceutical Healthcare Association (IPHA) at Dublin, Ireland, themed ‘Patient Care, Powered By Innovation’.

In the field of professional boxing, Ireland was and remains a global superpower and a role model. Yet in the field of biopharmaceutical innovation, Ireland does not step into the ring of greats:

  • Despite retaining the reputation of a global leader in advances biopharmaceutical manufacturing – with €10 billion invested over the past decade – ...
Continue Reading →
0

New Pugatch Consilium Study Shows How Countries Can Develop Biotech Industry

Posted by:

A Pugatch Consilium study released today commissioned by the Biotechnology Innovation Organization (BIO) highlights strategies, policies and best practices that have been successful in creating an environment in which biotechnology innovation can flourish around the world.

The fifth edition of the Building the Bioeconomy report shows the correlation between economies with pro-innovation policy frameworks and those achieving strong biotechnology outputs. By examining 28 different indicators ranging from public policy inputs to biotechnology outputs, the report provides a full and detailed ...

Continue Reading →
0

A New Era For Russian Biotechnology In 2030 – Remains To Be Seen And Proven

Posted by:

Professor Meir Pugatch spoke at the St. Petersburg International Economic Forum (SPIEF) in the panel: “Life Sciences in 2030: A New Era for Biotechnology” which took place on May 26, 2018 and included the Deputy Ministers of the Ministries of Health, Industry and Trade, and Agriculture of the Russian Federation, as well as Senior Executives of top MNCs in the private sector. Prof. Pugatch presented key highlights of Pugatch Consilium’s research concerning the enabling conditions for developing a competitive bioeconomy ...

Continue Reading →
0

Daniel Coriat Sharing the Results of the BCI 2017 | Hosted by the CIF

Posted by:

In Santiago de Chile, Daniel Coriat shared the results of the BCI 2017 with a distinguished audience at an event hosted by CIF, the local Chilean pharmaceutical trade association.  During the event, representatives of the Ministry of Economy and the Ministry of Foreign Affairs highlighted the importance that the BCI tool provides as empirical evidence of the effects of public policy.  Here Dan is being interviewed by a renowned journalist in Chile about the BCI:

http://www.infinita.cl/entrevistas/2018/05/09/daniel-coriat-director-consultora-pugatch-consilium

Continue Reading →
0

Is Taiwan Ready for the Top Spot?

Posted by:

Professor Meir Pugatch spoke today at the forum “Positioning Taiwan as an Asia-Pacific Biomedical R&D Hub” which took place the International Convention Center in Taipei, and included the Vice President of Taiwan and additional government officials.

Professor Pugatch presented a comprehensive analysis of Taiwan’s competitiveness in the biotech sector, as well as recent improvements to and remaining challenges in Taiwan’s path to leadership in global biotech innovation.

By utilizing a competitive mentality that views policy as instrumental in achieving economic and societal ...

Continue Reading →
0

Daniel Coriat on Colombia’s standing in the BCI report

Posted by:

As part of the coverage of the event celebrating 60 years of Afidro where industry, government, patient groups and other stakeholders gathered in Bogota on March 2018, a leading 24-hour news channels in Colombia interviews Pugatch Consilium’s Daniel Coriat on Colombia’s standing in the BCI report. Daniel explains how policies not geared to promote innovation hurt Colombia’s international standing and competitiveness in attracting foreign direct investment.

Listen to the interview

Continue Reading →
0
Page 1 of 5 12345